NeoGenomics (NEO) Tops Q3 EPS by 7c

NeoGenomics (NASDAQ: NEO) reported Q3 EPS of $0.00, $0.07 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $152 million versus the consensus estimate of $141.65 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
• DBS Group Downgrades RoboSense Technology (2498:HK) to Hold
• Marathon Petroleum (MPC) PT Raised to $450 at UBS